Rituximab-associated interstitial lung disease in fibrillary glomerulonephritis

Rituximab (RTX) is a chimeric monoclonal antibody against CD20+ B cells increasingly used to treat kidney disorders. RTX-induced pulmonary disease has been reported in patients treated for haematological disorders, and a few cases have been observed in patients with underlying rheumatological condit...

Descripción completa

Detalles Bibliográficos
Autores principales: Sainz-Prestel, Valeria, Hernandez-Perez, Jesus, Rojas-Rivera, Jorge, Milicua-Muñoz, José María, Egido, Jesus, Ortiz, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Clinical Cases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438396/
https://www.ncbi.nlm.nih.gov/pubmed/26064515
http://dx.doi.org/10.1093/ckj/sft081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438396/
https://www.ncbi.nlm.nih.gov/pubmed/26064515
http://dx.doi.org/10.1093/ckj/sft081

Ejemplares similares